CD226 and cancer: CD226 (also known as DNAX Accessory Molecule-1, DNAM-1, PTA-1, and TLiSA1) is a surface receptor that is expressed on some types of immune cells, such as T cells, NK cells, B cells and monocytes, which has been shown to be required for cancer immunosurveillance [8].